HEALOS FX BONE GRAFT SUBSTITUTE AND GRAFT MIXING AND DELIVERY SYSTEM— 510(k) K062495

Name: FDA 510(k) clearance K062495
Creator: U.S. Food and Drug Administration
Published: 2006-10-13

Substantially Equivalent

Depuy Spine, Inc.

FDA 510(k) clearance K062495 for HEALOS FX BONE GRAFT SUBSTITUTE AND GRAFT MIXING AND DELIVERY SYSTEM, Substantially Equivalent on 2006-10-13. Applicant: Depuy Spine, Inc.. Device class: 2.

Clearance details

Applicant: Depuy Spine, Inc.
Product code: Code MQV
Device class: Class 2
Regulation: 21 CFR 888.3045
Advisory panel: Orthopedic
Date received: 2006-08-25
Decision date: 2006-10-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Raynham, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MQV

view all

K262230 — Mg OSTEOREVIVE; Mg OSTEOCRETE2026-09-11
K260364 — Device 300419 Strip2026-06-02
K252797 — JAZBI Resorbable Bone Void Filler2026-05-26
K261008 — Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip +7 more2026-04-24
K253524 — Adaptos®Fuse Bone Graft2026-02-17

More clearances from Depuy Spine, Inc.

view all

K201831 — CONFIDENCE Spinal Cement System2020-08-31
K142185 — EXPEDIUM VERSE SPINE SYSTEM2014-11-19
K111136 — EXPEDIUM SPINE SYSTEM, VIPER SYSTEM, VIPER 2 SYSTEM2012-06-14
K121020 — VIPER SYSTEM2012-05-03
K110353 — MOUNTAINEER OCT SPINAL SYSTEM2011-04-07

Adverse events under product code MQV

product code MQV

Death: 6
Injury: 435
Total: 441

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.